Fistula in ano - Medium Biopsy 1-3 cm

Biopsy

Report in 288Hrs

At Home

No Fasting Required

Details

Histopathology of fistula tract.

₹370₹529

30% OFF

Fistula in ano - Medium Biopsy 1-3 cm

Why is it done?
- To obtain tissue samples from fistula tracts measuring 1-3 cm for histopathological examination and diagnosis
- To diagnose the underlying cause of anal fistulas, including infection, inflammation, malignancy, or granulomatous disease
- To rule out malignancy or unusual pathology in recurrent or chronic fistulas
- To guide treatment planning by identifying specific pathological findings and microorganisms
- Typically performed during anoscopic evaluation or surgical assessment of anal fistula disease
Normal Range
- Specimen Size: 1-3 cm (medium biopsy specimen)
- Normal Result: Benign tissue showing chronic inflammation, granulation tissue, fibrosis, and/or normal anal tissue architecture without malignancy or atypical features
- No dysplasia, malignancy, or suspicious cellular changes present
- Negative for special organisms (tuberculosis, fungal infections, etc.) unless specifically indicated
- Interpretation: Normal results support idiopathic cryptoglandular fistula and allow treatment planning; abnormal results may indicate alternative diagnoses
Interpretation
- Benign Findings: Chronic inflammation, granulation tissue, fibrosis, and squamous epithelium indicate simple cryptoglandular fistula; standard surgical treatment may proceed
- Malignancy: Squamous cell carcinoma or adenocarcinoma requires immediate surgical oncology consultation and modified treatment approach; may necessitate wider resection margins and possible chemotherapy/radiation
- Tuberculosis: Caseating granulomas with acid-fast bacilli require antituberculous therapy; surgical intervention should be deferred until infection is treated
- Crohn's Disease: Non-caseating granulomas indicate inflammatory bowel disease; requires gastroenterology evaluation and medical management with immunosuppressive therapy; surgical options may be limited
- Fungal Infections: Identification of fungal organisms (histoplasmosis, blastomycosis, etc.) requires specific antifungal therapy; surgical drainage may be supportive
- Dysplasia: Low-grade or high-grade dysplasia suggests malignant potential; requires closer surveillance, possible repeat biopsies, and discussion of aggressive treatment options
- Factors Affecting Results: Specimen size, site of biopsy collection, tissue fixation quality, presence of inflammatory changes, and patient immune status may influence pathological findings
Associated Organs
- Primary Organ System: Anal canal and rectum (colorectal system), anal sphincter complex
- Associated Conditions with Abnormal Results:
- Squamous cell carcinoma of anal canal (increased risk with HPV infection, immunosuppression, history of anal intercourse)
- Crohn's disease (may present as complex fistulizing disease)
- Tuberculosis (systemic infection affecting anorectal region)
- Recurrent or complex cryptoglandular fistulas
- Hidradenitis suppurativa (may present with fistulous tracts)
- Pilonidal disease with fistulization
- Potential Complications/Risks with Abnormal Results:
- Malignancy: Risk of metastatic disease, need for more aggressive surgical/oncological intervention
- Sepsis: Risk from severe infections (tuberculosis, abscess formation)
- Sphincter damage: Complex fistula disease may require sphincter-sparing procedures
- Chronic pelvic pain and fecal incontinence from extensive disease
Follow-up Tests
- If Malignancy Identified:
- CT chest/abdomen/pelvis for staging
- MRI pelvis for local disease assessment
- PET scan for metastatic evaluation if high-grade malignancy
- Oncology consultation for treatment planning
- If Tuberculosis Identified:
- Chest X-ray and pulmonary evaluation
- Tuberculin skin test and interferon-gamma release assay
- Infectious disease consultation for antituberculous therapy
- Contact tracing and evaluation of family members
- If Crohn's Disease Identified:
- Colonoscopy with ileoscopy for comprehensive IBD assessment
- Capsule endoscopy if small bowel involvement suspected
- Inflammatory markers (CRP, ESR, fecal calprotectin)
- Gastroenterology consultation for medical management
- If Benign Finding (Simple Cryptoglandular Fistula):
- Proceed with definitive fistula surgery (fistulotomy or sphincter-sparing technique based on anatomy)
- Postoperative follow-up at 2-4 weeks to assess healing
- Surveillance for recurrence at 6 and 12 months
- General Follow-up Considerations:
- Repeat biopsies if clinical suspicion remains high and initial biopsy non-diagnostic
- Anoscopy if dysplasia or malignancy detected
- MRI pelvis for complex or recurrent fistulas to assess anatomy
Fasting Required?
- Fasting: Yes, typically required
- Duration: 6-8 hours prior to the procedure
- Bowel Preparation:
- Enema on the morning of procedure or night before (usually 1-2 phosphate enemas) to clear rectum and lower colon
- Some practitioners may recommend full bowel prep (polyethylene glycol solution) if extensive evaluation planned
- Medications:
- Continue regular medications unless instructed otherwise
- Discontinue aspirin and anticoagulants 5-7 days prior if instructed (based on anesthesia type)
- NSAIDs should be avoided for 3-5 days pre- and post-procedure
- Additional Patient Preparation:
- Informed consent required discussing risks (bleeding, infection, sphincter damage)
- Void bladder before procedure
- Remove jewelry, dentures, and hearing aids before anesthesia
- Arrange transportation if sedation/general anesthesia planned
- Notify physician of allergies, bleeding disorders, or anticoagulation therapy

How our test process works!